Ontruzant and Chills - a phase IV clinical study of FDA data

Summary:

Chills is reported as a side effect among people who take Ontruzant (trastuzumab-dttb), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Perjeta, and have Breast cancer.

The phase IV clinical study analyzes which people have Chills when taking Ontruzant. It is created by eHealthMe based on reports of 517 people who have side effects when taking Ontruzant from the FDA, and is updated regularly.

What is Ontruzant?

Ontruzant has active ingredients of trastuzumab-dttb. eHealthMe is studying from 517 Ontruzant users. Check the latest studies of Ontruzant.

What is Chills?

Chills (felling of cold) is found to be associated with 2,554 drugs and 3,475 conditions by eHealthMe. Check the latest studies of Chills.

On Aug, 09, 2026

517 people reported to have side effects when taking Ontruzant.
Among them, 31 people (6.0%) have Chills.

Among these 31 people:

How long have people been on Ontruzant when they have Chills? *

What is the gender of people who have Chills when taking Ontruzant? *

female: 86.21 %
male: 13.79 %

What is the age of people who have Chills when taking Ontruzant? *

What are other drugs people take besides Ontruzant? *

What are other side effects people have besides Chills? *

Fever: 13 people, 41.94%
Dyspnea (difficult or laboured breathing): 10 people, 32.26%
High Blood Pressure: 9 people, 29.03%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 16.13%
Back Pain: 5 people, 16.13%
Skin Blushing/flushing (a sudden reddening of the face, neck): 5 people, 16.13%
Nausea And Vomiting: 5 people, 16.13%
Nausea (feeling of having an urge to vomit): 5 people, 16.13%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 16.13%
Feeling Hot: 5 people, 16.13%

What are the existing conditions these people have? *

Breast Cancer: 13 people, 41.94%
Breast Neoplasm (non cancerous tumour of breast): 4 people, 12.90%
Oesophageal Adenocarcinoma (a cancer tumour of an epithelium in oesophagus): 3 people, 9.68%
Breast Cancer Metastatic: 2 people, 6.45%
Oesophageal Adenocarcinoma Recurrent (reoccurrence of a cancer tumour of an epithelium in oesophagus): 1 person, 3.23%
Breast Cancer Female: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Ontruzant and have Chills?

- Check whether Chills is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ontruzant:

Ontruzant (517 reports)

Chills treatments and more:

Chills (145,628 reports)

Browse all side effects of Ontruzant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chills:

Chills (2,554 drugs)

Browse all the conditions that are associated with Chills:

Chills (3,475 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trastuzumab-dttb (the active ingredients of Ontruzant) and Ontruzant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.